Brendan M. O'Leary
Directeur/Membre du Conseil chez Silk Therapeutics, Inc.
Profil
Brendan M.
O'Leary is currently a Director at Silk Therapeutics, Inc., Evolved by Nature, Inc., AllosteRx Capital Management (Canada), Inc., and UMass Chan Medical School.
He has formerly served as an Independent Director at Proteon Therapeutics, Inc., Director at Serica Technologies, Inc., Locus Pharmaceuticals, Inc., Atritech, Inc., BioRexis Pharmaceutical Corp., Trius Therapeutics, Inc., Alacer Biomedical, Inc., Silk Medical Aesthetics, Inc., and Principal at Prism Venture Management LLC.
Dr. O'Leary completed his undergraduate degree at Middlebury College and obtained a doctorate from the Massachusetts Institute of Technology in 1999.
Postes actifs de Brendan M. O'Leary
| Sociétés | Poste | Début |
|---|---|---|
Silk Therapeutics, Inc.
 Silk Therapeutics, Inc. Specialty StoresRetail Trade Silk Therapeutics, Inc. provides silk protein solutions for human health. It sells its products through its online store. The firm’s PureProC, a film formulation that protects, stabilizes and delivers the use of vitamin C for duration with anti-aging and skin health benefits. The company was founded Gregory H. Altman and Rebecca Horan in June 2013 and is headquartered in Medford, MA. | Directeur/Membre du Conseil | - |
| UMass Chan Medical School | Corporate Officer/Principal | - |
Evolved by Nature, Inc.
 Evolved by Nature, Inc. TextilesProcess Industries Evolved by Nature, Inc. manufactures activated silk. The firm’s product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company was founded by Gregory Altman and Rebecca Lacouture in 2013 and is headquartered in Medford, MA. | Directeur/Membre du Conseil | - |
| AllosteRx Capital Management (Canada), Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Brendan M. O'Leary
| Sociétés | Poste | Fin |
|---|---|---|
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Private Equity Investor | 01/01/2020 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 11/09/2013 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/03/2008 |
Silk Medical Aesthetics, Inc.
 Silk Medical Aesthetics, Inc. Medical SpecialtiesHealth Technology Silk Medical Aesthetics, Inc. operates as a medical dermal filler company. It makes medical products used in the skin safer. The company was founded by Gregory Altman and Rebecca Lacouture and is headquartered in Medford, MA. | Directeur/Membre du Conseil | - |
Alacer Biomedical, Inc.
 Alacer Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Alacer Biomedical, Inc. distributes silk based biomaterial products for tissue rejuvenation. The company was founded on February 24, 2010 and is headquartered in Medford, MA. | Directeur/Membre du Conseil | - |
Formation de Brendan M. O'Leary
| Massachusetts Institute of Technology | Doctorate Degree |
| Middlebury College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Serica Technologies, Inc.
 Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Health Technology |
Silk Therapeutics, Inc.
Silk Therapeutics, Inc. Specialty StoresRetail Trade Silk Therapeutics, Inc. provides silk protein solutions for human health. It sells its products through its online store. The firm’s PureProC, a film formulation that protects, stabilizes and delivers the use of vitamin C for duration with anti-aging and skin health benefits. The company was founded Gregory H. Altman and Rebecca Horan in June 2013 and is headquartered in Medford, MA. | Retail Trade |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Finance |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
Atritech, Inc.
 Atritech, Inc. Hospital/Nursing ManagementHealth Services Atritech, Inc. is a private company that provides therapies to treat patients suffering from atrial fibrillation. They offer their services to clients who are at increased risk of stroke by offering permanent alternatives to medications. The company was founded in 2000 and is headquartered in Plymouth, MN. | Health Services |
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Alacer Biomedical, Inc.
Alacer Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Alacer Biomedical, Inc. distributes silk based biomaterial products for tissue rejuvenation. The company was founded on February 24, 2010 and is headquartered in Medford, MA. | Health Technology |
Silk Medical Aesthetics, Inc.
Silk Medical Aesthetics, Inc. Medical SpecialtiesHealth Technology Silk Medical Aesthetics, Inc. operates as a medical dermal filler company. It makes medical products used in the skin safer. The company was founded by Gregory Altman and Rebecca Lacouture and is headquartered in Medford, MA. | Health Technology |
Evolved by Nature, Inc.
Evolved by Nature, Inc. TextilesProcess Industries Evolved by Nature, Inc. manufactures activated silk. The firm’s product is pure silk in liquid form, a regenerative technology made from discarded silkworm cocoons. The company was founded by Gregory Altman and Rebecca Lacouture in 2013 and is headquartered in Medford, MA. | Process Industries |
| AllosteRx Capital Management (Canada), Inc. |